|
|
|
Volumn 50, Issue 5, 2009, Pages 404-412
|
|
Angiogenesis regulated by VEGF and its receptors and its clinical application.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
HYBRID PROTEIN;
INDOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SORAFENIB;
SUNITINIB;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
ANGIOGENESIS;
ANIMAL;
DRUG ANTAGONISM;
DRUG DESIGN;
GENETICS;
HUMAN;
IMMUNOLOGY;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
TUMOR EMBOLISM;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
DRUG DESIGN;
HUMANS;
INDOLES;
NEOPLASMS;
NEOPLASTIC CELLS, CIRCULATING;
NEOVASCULARIZATION, PATHOLOGIC;
NEOVASCULARIZATION, PHYSIOLOGIC;
PYRIDINES;
PYRROLES;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
SIGNAL TRANSDUCTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 79958264145
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (61)
|
